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Abstract. It has been demonstrated that Mycobacterium leprae, are capable of taking up  
uracil and incorporating it into trichloroacetic acid-insoluble materials, both as free 
suspension of bacteria, as well as when they are inside the macrophages, a host cell for their 
in vivo survival. Same amount of bacteria show better incorporation inside macrophages 
than as free bacterial suspension. Both types of incorporation are inhibited by rifampicin an 
antileprosy drug and an RNA synthesis inhibitor. Thus uracil uptake by Mycobacterium 
leprae inside macrophages has been used for standardising a rapid in vitro viability assay for 
the leprosy causing bacteria. 
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Introduction 
 
Mycobacterium leprae, the causative organism for leprosy is an intracellular obligate 
pathogen. In patients suffering from lepromatous leprosy the bacteria are seen inside 
several host cells,but primarily macrophages in various tissues and schwann cells of 
peripheral nerves. These two cell types are important for immune functions and 
normal nerve functions, respectively. It is well documented that those susceptible to 
lepromatous leprosy, have poor cell mediated immunity (Bloom and Mehra, 1984) a 
function in which macrophages play an important role as antigen presenting cell. 
The patients also suffer from failure of nerve function leading to neuropathy, 
basically expressed as features related to damage in the myelin of myelinated nerves 
and the Schwann cells of unmyelinated peripheral nerves (Shetty et al., 1980). Thus 
the understanding of host-pathogen interaction is basic necessity in explaining the 
pathogenesis in leprosy especially lepromatous leprosy. 
The information available regarding metabolism of M. leprae was fully described 
recently by Wheeler (1984). The nucleic acid metabolism as studied by the uptake 
and incorporation of labelled pyrimidines and purines was also described by him. In 
analysing the reported ability of M. leprae from armadillo to incorporate the 
precursor of nucleic acid (Khanolkar et al., 1978; Drutz and Cline, 1972; Prasad and 
Nath, 1981; Nath et al., 1982; Khanolkar and Wheeler, 1983) it was concluded by 
Wheeler (1984) that purines like, hypoxanthine and adenosine were better precursors 
than pyrimidines like thymidine or uracil. However it is noteworthy that all 
experimental evidence by Nath and her colleagues, cited above, clearly indicate 
utility of thymidine as a metabolic precursor for determining viability and drug 
sensitivity of M. leprae, phagocytosed by macrophages. There are other in vitro assay 
systems for viability of M. leprae have also been described. They include the 
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dihydroxyphenylalanine (DOPA) uptake (Ambrose et al., 1978) and ATP assay 
system (Dhople and Hanks, 1980). 
Viability of M. leprae inside the host cells cannot be judged by size, shape, 
morphology or staining property of the bacteria. Such a procedure has always been 
arbitrary. Thus the dynamic metabolism expressed by M. leprae inside the host cell 
has to be used. Once such assay systems are well established, we could use them for 
determining the nature of M. leprae under various conditions that affect the viability. 
Such conditions involve exposure to antileprosy drugs, exposure to immune 
competent cells (lymphocytes) and cell products (lymphokines). These products could 
alter the viability of M. leprae. Thus it is essential to have such assay systems and 
some of them have already been identified (Nath et al., 1982; Ambrose et al., 1978; 
Vithala et al., 1983; Mankar et al., 1984). 
In this paper we describe use of uracil as a precursor to assess the metabolism of 
M. leprae, inside macrophages. Potential use of uracil for determining viability of 
mycobacteria like BCG, was identified by Rook et al. (1981), who later adopted it to 
show killing of BCG inside macrophages by activated lymphocytes (Rook et al., 
1985). We have adopted a closely similar procedure with M. leprae. 
This paper also presents detailed data to demonstrate that M. leprae are able to 
incorporate uracil even as free suspension and the two systems one as the free 
suspension and other inside host cells have been compared. 
 
 
Materials and methods 
 
Preparation of N-2 Hydroxypiperarine N-2 ethane sulphonic acid Buffer
 
N-2 Hydroxypiperarine N-2 ethane sulphonic acid (HEPES, Sigma Chemicals Co., 
USA) Powder—0·15 M, NaCl–0·15 Μ and MgSO47H2O–0·1 mM were dissolved to 
make a 100 ml solution with distilled water; and pH was adjusted to 7·2 with 1N 
HCl, autoclaved (15 lbs./121°C/30 min) and stored for use. 
 
 
Preparation of M. leprae 
 
Μ. leprae was obtained from tissue of leprosy patients as per the method of Ambrose 
et al. (1978). Bacteria obtained were acid fast stainable and were used only after 
ascertaining that they were free from other rapidly growing contaminating bacteria, 
including other mycobacterial strains. M. leprae normally does not grow in the 
common mycobacterial medium. 
 
 
Assay of [3Η]-uracil incorporation in M. leprae 
 
[3H]-Uracil labelled in positions 5–6 was obtained from Amersham Radiochemical
Centre,London, (sp. act. 35 Ci/mmol). Reaction mixture containing 20×l06
bacteria, HEPES Buffer, pH 7·2 and 1 µCi [3H]-uracil in a final volume of 0·5 ml/ 
tube was incubated at 34°C for 6 days. Control tubes containing same materials, 
except that the bacilli pretreated with 8% formaldehyde for 24 h were used. After 
incubating the bacteria aseptically for 6 days, both the control and experimental
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tubes were centrifuged at 5000g. To the residue, 20% cold trichloroacetic acid (TCA) 
was added. The precipitated material obtained after acid addition, was filtered 
through Millipore filter (0·22 µm pore size) which was then washed with methanol 
and dried. Use of methanol was just to remove the aqueous layer on the filter only. 
The filter paper was placed in vial containing 10 ml of Bray's scintillation fluid (Bray, 
1960), and with the help of Kontron MR 300 scintillation counter the radioactivity 
as dpm of [3H] -uracil in TCA insoluble material was reported. 
 
 
Action of drugson incorporation 
 
While the bacteria were being incubated with the labelled precursor [3H] -uracil; they 
were exposed to Dapsone (DDS) or rifampicin at concentration ranging from 0·5 µg 
10 µg/ml. This was to find out whether the known anti-. leprae drugs can block the 
metabolism of M. leprae and thus the incorporation of the precursor. DDS was 
obtained from Burroughs Wellcome, Bombay and rifampicin from Sigma Chemical 
Co., St. Louis, Missouri, USA. 
 
 
Macrophage preparation 
 
Macrophages were obtained from Swiss white mice. The mice were injected with 5 ml 
of minimum essential medium (MEM) containing inactivated human AB type serum 
(to 20% level) into peritoneal cavity, after killing the animal by cervical dislocation. 
The peritoneal fluid was collected from the animal by agitating the cavity with the 
medium and 0·7 ml of the collected fluid containing the cells was distributed in 
Leighton tubes. Tubes were then incubated at 37°C in 5% CO2 atmosphere. The 
medium was changed every 24 h, so as to remove non adherent cells and the cell 
culture was thus matured for 3 days. This resulted in fairly good monolayers of 
adherent macrophages which were phagocytic and largely free from other types of 
cells. 
 
 
[ 3H]-Uracil incorporation studies with macrophages containing M. leprae 
 
After getting the monolayer of adherent macrophages on the flat side of Leighton 
tubes (3 day old cultures), the tubes were divided in 3 sets. One set was infected with 
viable M. leprae and another with heat killed M. leprae (5 × 106 from human or 
armadillo tissue). The third set did not receive any M. leprae and was used as a 
control. After 24 h, all tubes were labelled with 1 µCi of [3H]-uracil. After 6 days of 
incubation at 37°C in 5% CO2 atmosphere, the cultures were terminated. Medium 
was drained from all tubes and one ml of fresh saline was added and tubes were kept 
in cold (4oC) for 15 min. The cells were scrapped from the surface of glass with 
silicone rubber policeman and using a small aliquot of the suspension, the 
macrophage cell count was obtained with a haemocytometer. After two washes with 
saline, macrophages were treated with 20 % cold TCA. The precipitated material was 
centrifuged at 2500 g and washed with methanol. The radioactivity was determined 
as described in the previous paragraph. The incorporation was represented as 
 dpm/106 macrophages. 
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Incorporation associated with M. leprae alone using the macrophages containing  
M. leprae 
 
In experiments similar to those described above, cultures exposed to M. leprae  
(5×106/tube heat killed and live) and the precursor ([3H]-uracil) after incubation for 
6 days were treated differently. The macrophages after recovery were lysed by 
freezing and thawing (8 cycles). The tissue debris was separated from bacteria by 
centrifugation at 1000 g for 15 min followed by bacterial separation by centrifuging 
at 5000 g for 30 min. Bacterial count was determined microscopically with acid fast 
staining by the Ziehl Neelsen method (Cruickshank, 1968). After treating the bacteria 
with 20% cold TCA, the incorporation associated with the precipitated bacteria was 
recorded as dpm/ 1 × 106 M. leprae. 
 
 
Inhibition of incorporation by rifampicin 
 
The M. leprae that were used to infect the macrophages were preincubated for 3 days 
with rifampicin (10 µg/ml) and added to macrophage cultures which were earlier 
exposed to rifampicin (10 µg/ml) for 24 h before the addition of M. leprae. The drug 
concentration was kept as 10 µg/ml since we wanted a definite action on the 
bacteria and the minimum inhibitory concentration with this type of assay system is 
yet to be worked out. The cultures were then exposed to precursor [3H]-uracil and 
incubated in the presence of rifampicin (10 µg/ml). The control cultures had no drug 
treatment either to the bacteria or macrophages. The incorporation of the precursor 
was determined in the bacteria as described earlier. 
 
 
Results 
 
Six different M. leprae isolates from human leprosy nodules and two different
M. leprae preparations from infected armadillo tissue showed incorporation of [3H]- 
uracil in TCA insoluble product, when 20 × 106 bacteria were incubated with 1 µCi 
of labelled uracil. In all the cultures, the live M. leprae showed significantly higher 
incorporation than formalin treated M. leprae (table 1). However the formalin 
treated bacteria did not show low level of incorporation, consistently in all 
experiments, even though the level in each experiment was much less than that of the 
corresponding sample with live M. leprae. 
In these experiments 20 × 106 bacteria were used. Before this was adopted, the
level of incorporation when different number of bacteria exposed to same amount of
uracil was also determined and this showed that increasing bacterial level resulted in 
higher incorporation, though not at a linear rate (data not presented). The non 
linearity may be due to different level of viability in each suspension since 
homogenous distribution of clumpy M. leprae is difficult.
 
Inhibition of uptake by drugs 
 
The uracil uptake by the bacteria was indicated as an apparent metabolic function 
by the inhibition of uptake by two anti M. leprae drugs, DDS and rifampicin (table 
2). In 5 different experiments (3 from spleen, and one each from nodule and leproma), 
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Table  1 .   Incorporat ion  o f  [ 3H]-uraci l  (as  dpm)  by  M. leprae  
(armadillo and human).  
 
All values are average of duplicates. 
Radioactivity is expressed in dpm/20 × 106 M. leprae. 
BI, Bacterial Index (Bacillary load). 
MI, Morphological Index (live). 
Difference between killed and live M. leprae is significant. P<0·001  
S.D., Standard deviation. 
 
 
Table 2. Incorporation of [3 H]-uracil by M. leprae (Armadillo) represented as 
dpm/20 × 106 M. leprae in the presence of antileprosy drugs (DDS and rifampicin). 
*The data with armadillo M. leprae from spleen (Ar–3 spleen) is an average value of 3 
separate experiments from 3 separate spleen tissues. 
All values are average of duplicates (in all other experiments) 20 × 106 Μ. leprae was used. 
S.D., Standard deviation. 
 
 
using armadillo derived M. leprae, the inhibitory activity on incorporation was 
demonstrable by 0·1–10 µg/ml of DDS and 0·5–10 µg/ml rifampicin added for the 
incubation mixture. The inhibition was revealed by lowered level of precursor 
incorporation in the drug treated M. leprae as compared to the live control 
M. leprae. 
 
 
Μ. leprae from clinically relapsed and normal patients 
 
M. leprae obtained from clinically relapsed or untreated patients (3) were also tested 
for ability to incorporate [3H]-uracil in the presence and absence of rifampicin an 
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inhibitor of RNA synthesis. It was found that M. leprae from all the 3 patients 
showed no susceptibility to DDS and rifampicin. This was indicated by the level of 
incorporation by M. leprae in the presence of these drugs remaining similar to that of 
live M. leprae (table 3). On the other hand M. leprae from armadillo and some 
untreated patients were susceptible to DDS and rifampicin. 
 
 
Table 3. Incorporation of [3H]-uracil by M. leprae (human) in presence of antileprosy 
drugs (DDS and rifampicin). 
 
All values are average of duplicates. 
Quantity of uracil incorporates is expressed as dpm/20 × 106 M leprae 
S.D., Standard deviation. 
BI/MI, Bacterial Index (load)/Morphological Index (live). 
 
Uptake of uracil by M. leprae phagocytosed by macrophages 
 
It was interesting to determine the level of uracil taken up by M. leprae phagocytosed by 
the macrophages, so as to compare with the ability of free M. leprae. The experiment 
 with armadillo M. leprae phagocytosed by macrophages showing the level of 
incorporation in 1×106 macrophages indicated, that discernable level of 
 incorporation was consistent in all the 8 experiments, even though the level of 
incorporation was different in each of the experiment. The level of M. leprae used 
 was same in all cases (5 × 106 bacteria) and equal amount of phagocytosis by the 
macrophages is assumed to occur (table 4). 
 
 
Increase in uptake of precursor by M. leprae inside the macrophages 
 
Earlier, different concentration of M. leprae was used in free suspension with the 
precursors  and we found, that the incorporation was insignificant and not 
discernable when the M. leprae used was less than 5 × 106 (data not presented). Thus 
it was necessary to compare the level of incorporation of uracil by M. leprae in a 
quantum less than 5 × 106 as free bacteria in suspension and same amount of 
M. leprae phagocytosed by macrophage cultures. Data provided (table 5) show level of 
incorporation by 1 × 106 M. leprae under the above two different conditions is 
significantly different. M. leprae (1 × 106) inside the macrophages showed several fold 
higher incorporation indicating a facilitation of increased uptake of uracil by M. 
leprae when they were inside the macrophages. 
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Table 4. Experimental data showing incorporation of [3H]-uracil (as dpm) by  
M. leprae inside macrophages. 
 
Radioactivity is expressed as dpm/1 × 106 macrophages. Μ. leprae 5 × l06/tube. 
 
 
Table 5. Comparison of incorporation by M. leprae (armadillo or human) in buffer and 
inside macrophages as dpm/1 × 106 M. leprae. 
 
L–F Live, formalin treated. 
L–H.K.–Live, heat killed M. leprae. 
 
 
Inhibition of such increased uptake by drugs 
 
The increased incorporation of uracil by M. leprae while they were inside the 
macrophages was tested for inhibition with rifampicin. Data in table 6 show that in 
the presence of rifampicin (10 μg/ml) the increased incorporation of uracil is 
drastically reduced indicating that the uptake is a true metabolic process. 
 
 
Discussion 
 
It is very likely that uracil is not a preferred metabolite of M. leprae towards nucleic 
acid metabolism as suggested by Wheeler et al. (1984). However as compared to low 
incorporation obtained in armadillo derived bacteria by Khanolkar and Wheeler 
(1983), our experiments show that longer incubation time upto 6 days show 
462 Sunanda Vejare and Mahadevan 
 
Table 6. Incorporation of [3H]-uracil by M. leprae (armadillo and human) inside
macrophages (1 × 106) in presence of RFP). 
 
*From patients. 
Incorporation is expressed as dpm/ 1× 106 M. leprae. 
 
incorporation of radioactivity significant enough to measure as acid insoluble 
component. However as a quantity in p mol, the incorporation is very low. Several 
observations show that the uptake of uracil is a metabolic activity. The uptake is 
extremely low in formalin treated bacteria. The uptake is proportional to bacteria 
exposed to the metabolite and also dependent on period of incubation, and further it 
is blocked by anti M. leprae drugs like DDS and more particularly by rifampicin, an 
inhibitor of RNA synthesis. The incorporation of uracil was first demonstrated by 
in vitro grown acid fast bacteria derived from leprosy nodule (data not presented) 
and later tested with Μ. leprae from leprosy nodules as well as infected armadillo 
tissues. But results presented here are only with M. leprae, from the human and 
armadillo tissues because of obvious interest in this group of pathogenic mycobacteria. 
The clinically relapsed patient who was diagnosed as having drug resistant 
bacteria, showed M. leprae in his tissue with resistance to the drug. Even an 
untreated patient showed primary resistance to the drug (table 3). 
It is clear that M. leprae are capable of taking up uracil and using it as a meta 
bolite to some extent as indicated previously by Wheeler et al. (1984). The question 
that arose was, does this happen inside a host cell? If so, is there a modification in the 
level of incorporation? Thus comparison was made between the total uptake of uracil 
by free M. leprae in suspension and M. leprae phagocytosed by macrophages. The 
experimental data provided in table 5 clearly showed an equal amount of M. leprae 
could have higher level of incorporation inside the host cells than as a free 
suspension. This could be due to some modification or activation of the metabolism 
of M. leprae inside the cells which facilitated increased uptake. This could also 
account for the consistent uptake of thymidine with fewer bacteria inside the 
macrophages (Prasad et al., 1981; Nath et al., 1982) as compared to poor or no 
uptake of thymidine by greater number of bacteria as free cell suspension 
(Khanolkar et al., 1978). Even though the conditions of treatment of free M. leprae 
and M. leprae inside macrophages appear different while studying the uptake of 
uracil; they are the most appropriate and optimum conditions for each of the type of 
the uptake system. Thus a comparison of the system appears justified. 
From these observations and that of Nath et al. (1982), it is suggested that during 
early hours of incubation (about 120 h) of M. leprae, there is an activation of the 
metabolism of the bacteria inside the macrophages.
It is thus clear that uracil can be used as a metabolic marker for determining 
viability, monitor maintenance of the viability and drug sensitivity of M. leprae while 
they are inside the macrophages and also to some extent while they are in free 
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suspension. The advantage of determining viability inside the macrophages would be 
that one could determine the effect of immunomodulators as well. This is important 
in a disease like leprosy in which the patients have poor or no cell mediated 
immunity. We have recently used macrophages phagocytosed M. leprae and uracil 
uptake to show effect of immunomodulation by lymphokines, and immunosti 
mulants on the viability of M. leprae (data under publication). 
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